Ceres, Inc., an agricultural biotechnology company, announced today financial results for the three months ended May 31, 2015.
The results shows Rise in Revenues by 0.3 Million to $1.1 million and EPS was -$0.98 per share.
Fiscal Q3 2015 Highlights vs. Same Year-ago Quarter
Total revenues increased by $0.3 million to $1.1 million
Cost of product sales increased by $0.3 million to $0.9 million
Net Loss of $5.9 million, or -$0.98 per share, compared to a net loss of $7.7 million, or -$1.35 per share.
Cash and cash equivalents and marketable securities totaled $9.1 million.
View the full earnings release here.